Skip to content

Study on Dynamic Changes of Serum IGF-1 Post-Cerebral Hemorrhage and Its Prognostic Correlation

Study on the Dynamic Changes of Serum IGF-1 After Cerebral Hemorrhage and Its Correlation With Prognosis of Patients

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500105434
Enrollment
Unknown
Registered
2025-07-03
Start date
2025-07-09
Completion date
Unknown
Last updated
2025-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracerebral Hemorrhage (ICH)

Interventions

Case series:No intervention

Sponsors

Shengjing Hospital Affiliated to China Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 75 years old; 2. Patients with intracerebral hemorrhage (ICH) with NIHSS score >=5; 3. No history of cerebrovascular diseases with residual functional deficits before brain injury; 4. Admitted to the hospital within 72 hours after injury; 5. BMI <=28;

Exclusion criteria

Exclusion criteria: 1. Patients with severe cardiac, hepatic, renal, or pulmonary dysfunction; 2. Glycated hemoglobin >9.0% at screening; 3. History of hypothalamic-pituitary related diseases or severe endocrine disorders; 4. Use of drugs affecting endocrine function (such as glucocorticoids, growth hormone) within the past six months; 5. Pregnant patients;

Design outcomes

Primary

MeasureTime frame
Insulin-like Growth Factor-1 (IGF-1);

Secondary

MeasureTime frame
Growth Hormone (GH);Insulin-like Growth Factor Binding Protein-3 (IGFBP-3);

Countries

China

Contacts

Public ContactYin Yanmei

Shengjing Hospital Affiliated to China Medical University

yym15998315189@163.com+86 189 4025 9354

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026